Complete Genomics (GNOM) +9.8% premarket after announcing it's laying off ~20% of its workforce to cut costs and has hired a financial adviser to help it explore strategic options including a possible sale of the company. GNOM says it is delaying expanding its monthly genome capacity until customer demand increases.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at MarketWatch.com (Nov 26, 2012)
at MarketWatch.com (Oct 15, 2012)
at MarketWatch.com (Sep 17, 2012)
at Fox Business (Aug 31, 2012)
at MarketWatch.com (Jun 5, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs